Search Result |
Top |
Entry | Name | Description | Category | Pathway | Gene |
---|---|---|---|---|---|
H01713 | Diffuse panbronchiolitis | Diffuse panbronchiolitis (DPB) is a chronic inflammatory lung disease, which predominantly affects East Asians. Clinically, DPB is characterized by chronic inflammation of the respiratory bronchioles and ... | Respiratory system disease | ||
H01718 |
Kawasaki disease Mucocutaneous lymph node syndrome |
... or three of these findings. The standard treatment of acute KD is intravenous immunoglobulin (IVIG) infusion and aspirin. However, 10-20% of patients show resistance to IVIG therapy and present higher risk ... | Immune system disease | ||
H01721 |
Anti-glomerular basement membrane (GBM) disease Goodpasture syndrome |
... (mainly immunoglobulin G-1) resulting in progressive crescentic glomerulonephritis and, frequently, diffuse pulmonary alveolar hemorrhage. Clinically, GS is characterized by pulmonary hemorrhage and renal ... | Immune system disease | ||
H01735 | Lymphangiomatosis | ... presentation, including micro- and macrocystic isolated lymphatic malformations, thoracic and intraabdominal diffuse lymphangiomatosis, and osseous and soft-tissue presentations known as Gorham disease. The disease ... | Neoplasm | ||
H01807 | Hereditary diffuse leukoencephalopathy with spheroids | Hereditary diffuse leukoencephalopathy with spheroids (HDLS) is an autosomal dominant central nervous system disease with variable clinical presentations, including personality and behavioral changes, ... | Neurodegenerative disease |
(HDLS1) CSF1R [HSA:1436] [KO:K05090] (HDLS2) AARS1 [HSA:16] [KO:K01872] |
|
H01841 | Acute encephalopathy with biphasic seizures and late reduced diffusion | Acute encephalopathy with biphasic seizures and reduced diffusion (AESD) is a syndrome of encephalopathy characterized by biphasic seizures. The etiology of AESD has been attributed to viral infection ... | Nervous system disease | ||
H01847 |
Thrombocytopenia-absent radius syndrome TAR syndrome |
... variants and a null allele in RBM8A. Clinical management is based on presentation, with platelet transfusions as required for thrombocytopenia and orthopedic intervention for functional optimization of upper ... | Congenital malformation | RBM8A [HSA:9939] [KO:K12876] | |
H01851 | Congenital scoliosis associated with rib anomalies | ... segmentation. Patients with congenital scoliosis frequently have other associated anomalies. Sometimes rib fusion or absence can be observed along with the spinal anomalies since ribs are formed in close association ... | Congenital malformation | ||
H01854 | Metacarpal 4-5 fusion | Metacarpal 4-5 fusion (MF4) is a rare congenital malformation of the hands characterised by the partial or complete fusion of the fourth and fifth metacarpal bones. The anomaly manifests clinically as ... | Congenital malformation | FGF16 [HSA:8823] [KO:K04358] | |
H01875 | Infantile hepatic hemangioma | ... benign hepatic vascular tumor in the first year of age. They are sub-classified in focal, multiple and diffuse lesions, based on degree of unaffected liver parenchyma. Most lesions are clinically silent and ... | Neoplasm | ||
H01908 | Carey-Fineman-Ziter syndrome | ... mutations in MYMK cause CFZS. Myomaker, encoded by MYMK, is expressed on the cell surface of myoblasts during fusion. Fusion of myoblasts is essential for the formation of multi-nucleated muscle fibres. | Congenital malformation |
(CFZS1) MYMK [HSA:389827] [KO:K24577] (CFZS2) MYMX [HSA:101929726] [KO:K24578] |
|
H01990 |
Muenke syndrome Muenke craniosynostosis |
... syndrome is an autosomal dominant disorder characterized by coronal suture craniosynostosis, hearing loss, developmental delay, carpal and tarsal fusions, and the presence of the mutation P250R in FGFR3 gene. | Congenital malformation | FGFR3 [HSA:2261] [KO:K05094] | |
H02118 |
Agnathia-otocephaly complex Otocephaly |
... by mandibular hypoplasia or agnathia, ventromedial auricular malposition (melotia) and/or auricular fusion (synotia), and microstomia with oroglossal hypoplasia or aglossia. The etiologic causes of otocephaly ... | Congenital malformation | PRRX1 [HSA:5396] [KO:K09329] | |
H02160 | Craniosynostoses | Craniosynostosis (CRS) is the premature fusion of the cranial sutures and secondary distortion of skull shape. | Congenital malformation |
(CRS1) TWIST1 [HSA:7291] [KO:K09069] (CRS2) MSX2 [HSA:4488] [KO:K09341] (CRS3) TCF12 [HSA:6938] [KO:K15603] (CRS4) ERF [HSA:2077] [KO:K09434] (CRS5) ALX4 [HSA:60529] [KO:K09451] (CRS6) ZIC1 [HSA:7545] [KO:K09224] (CRS7) SMAD6 [HSA:4091] [KO:K04677] |
|
H02226 |
Cardiospondylocarpofacial syndrome Forney syndrome |
... is characterized by growth retardation, dysmorphic facial features, brachydactyly with carpal-tarsal fusion and extensive posterior cervical vertebral synostosis, cardiac septal defects with valve dysplasia ... | Congenital malformation | MAP3K7 [HSA:6885] [KO:K04427] | |
H02254 | Craniosynostosis and dental anomalies | ... 11 receptor, alpha. It has been suggested that IL11 signaling is essential for the normal development of craniofacial bones and teeth and that its function is to restrict suture fusion and tooth number. | Congenital malformation | IL11RA [HSA:3590] [KO:K05056] | |
H02264 | Palmoplantar keratoderma, Nagashima type | Palmoplantar keratoderma Nagashima type (PPKN) is an autosomal recessive nonsyndromic diffuse palmoplantar keratosis characterized by diffuse hyperkeratosis with redness, expanding on to the dorsal surfaces ... | Congenital malformation | SERPINB7 [HSA:8710] [KO:K13964] | |
H02266 | Palmoplantar keratoderma, Bothnian type | ... prevalent in the north of Sweden, along the Gulf of Bothnia. The clinical characteristics of PPKB include diffuse, homogeneous, and even palmoplantar hyperkeratosis with swollen stratum corneum, which distinctively ... | Congenital malformation | AQP5 [HSA:362] [KO:K09867] | |
H02275 |
Batten disease Spielmeyer-Vogt disease Juvenile neuronal ceroid lipofuscinoses |
Batten disease, also known as Juvenile neuronal ceroid lipofuscinoses (JNCL), is an autosomal recessive lysosomal disease. It manifests with vision loss, followed by seizures and progressive neurodegeneration ... | Inherited metabolic disorder, Lysosomal disease | CLN3 [HSA:1201] [KO:K12389] | |
H02276 |
Kufs disease Adult-onset neuronal ceroid lipofuscinosis |
Kufs disease, an adult-onset neuronal ceroid lipofuscinosis (NCL), differs from most other forms of NCL because the retina is not involved, and vision is preserved. The clinical presentation has been divided ... | Inherited metabolic disorder, Lysosomal disease |
CLN6 [HSA:54982] [KO:K12359] DNAJC5 [HSA:80331] [KO:K09525] CTSF [HSA:8722] [KO:K01373] |
|
H02277 |
Santavuori-Haltia disease Infantile neuronal ceroid lipofuscinosis |
Santavuori-Haltia disease, also known as the infantile neuronal ceroid lipofuscinosis (INCL), is a rare but one of the most lethal inherited neurodegenerative lysosome storage disorders of childhood. Patients ... | Inherited metabolic disorder, Lysosomal disease | PPT1 [HSA:5538] [KO:K01074] | |
H02278 |
Jansky-Bielschowsky disease Late infantile neuronal ceroid lipofuscinosis |
Jansky-Bielschowsky disease, a classical late infantile neuronal ceroid lipofuscinosis (LINCL), is an autosomal recessive neurodegenerative disease with onset of symptoms between 2 and 4 years of age. ... | Inherited metabolic disorder, Lysosomal disease | TPP1 [HSA:1200] [KO:K01279] | |
H02279 | Cathepsin D deficiency | Cathepsin D deficiency underlies congenital neuronal ceroid-lipofuscinosis (NCL). It represents the earliest-onset and the most aggressive form of the NCL, leading to extreme brain atrophy and death soon ... | Inherited metabolic disorder, Lysosomal disease | CTSD [HSA:1509] [KO:K01379] | |
H02328 | Sifrim-Hitz-Weiss syndrome | ... palatal abnormalities, ventriculomegaly, and hypogonadism as well as additional findings such as bone fusions. It has been reported that de novo mutations in CHD4 cause this disease. CHD4 is a core component ... | Congenital malformation | CHD4 [HSA:1108] [KO:K11643] | |
H02418 | Non-Hodgkin lymphoma | ... aggressive or indolent. Aggressive NHL is fast-growing disease. It mainly includes mantle cell lymphoma, diffuse large B-cell lymphoma, Burkitt's lymphoma, lymphoblastic lymphoma and peripheral T-cell lymphoma ... | Cancer |
RAD54L [HSA:8438] [KO:K10875] RAD54B [HSA:25788] [KO:K10877] CASP10 [HSA:843] [KO:K04400] PRF1 [HSA:5551] [KO:K07818] |
|
H02424 | Primary central nervous system lymphoma | ... non-Hodgkin lymphoma (NHL) confined to the brain, leptomeninges, eyes, or spinal cord. Most PCNSLs are diffuse large B-cell lymphoma (DLBCL; 90%), with the remainder consisting of T-cell lymphomas, poorly characterized ... | Cancer |
MYD88 (mutation) [HSA:4615] [KO:K04729] CD79B (mutation) [HSA:974] [KO:K06507] CARD11 (mutation) [HSA:84433] [KO:K07367] TNFAIP3 (mutation) [HSA:7128] [KO:K11859] HLA-DRB5 (deletion) [HSA:3127] [KO:K06752] CDKN2A (deletion) [HSA:1029] [KO:K06621] |
|
H02434 | Diffuse large B-cell lymphoma, not otherwise specified | Diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS) is the most common type of DLBCL. DLBCL accounts for 30-40% of all non-Hodgkin lymphomas (NHL), making it the most prevalent form of ... | Cancer |
EZH2 (mutation) [HSA:2146] [KO:K11430] CREBBP (mutation/deletion) [HSA:1387] [KO:K04498] EP300 (mutation/deletion) [HSA:2033] [KO:K04498] GNA13 (mutation) [HSA:10672] [KO:K04639] GNAI2 (mutation) [HSA:2768] [KO:K04346] TNFRSF14 (mutation) [HSA:8764] [KO:K05152] BCL6 (mutation) [HSA:604] [KO:K15618] MYC (chromosomal translocation) [HSA:4609] [KO:K04377] PTEN (deletion) [HSA:5728] [KO:K01110] BCL2 (chromosomal translocation / mutation) [HSA:596] [KO:K02161] CARD11 (mutation) [HSA:84433] [KO:K07367] CD79A (mutation) [HSA:973] [KO:K06506] CD79B (mutation) [HSA:974] [KO:K06507] TNFAIP3 (mutation/deletion) [HSA:7128] [KO:K11859] MYD88 (mutation) [HSA:4615] [KO:K04729] CDKN2A (deletion) [HSA:1029] [KO:K06621] CDKN2B (deletion) [HSA:1030] [KO:K04685] PRDM1 (mutation/deletion) [HSA:639] [KO:K24501] MLL2 (mutation) [HSA:8085] [KO:K09187] MLL3 (mutation) [HSA:58508] [KO:K09188] B2M (mutation/deletion) [HSA:567] [KO:K08055] CD58 (mutation/deletion) [HSA:965] [KO:K06492] TP53 (mutation) [HSA:7157] [KO:K04451] MEF2B (mutation) [HSA:100271849] [KO:K09261] FOXO1 (mutation) [HSA:2308] [KO:K07201] |
|
H02440 | Fleck retina, familial benign | ... appearance. Affected individuals are asymptomatic, but fundus examination reveals a striking pattern of diffuse, yellow-white, fleck-like lesions extending to the far periphery of the retina but sparing the foveal ... | Nervous system disease | PLA2G5 [HSA:5322] [KO:K01047] | |
H02542 | Acute promyelocytic leukemia | ... characterized by a balanced reciprocal translocation between chromosomes 15 and 17, which results in the fusion between the promyelocytic leukemia (PML) gene and retinoic acid receptor alpha (RARA). The majority ... | Cancer |
PML-RARA (translocation) [HSA:5371 5914] [KO:K10054 K08527] PLZF-RARA (translocation) [HSA:7704] [KO:K10055] NUMA1-RARA (translocation) [HSA:4926] [KO:K16808] |
|
H02581 | Juberg-Hayward syndrome | ... microcephaly, ptosis, short stature, hypoplasia or aplasia of thumbs, and dislocation of radial head and fusion of humerus and radius leading to elbow restriction. It has been reported that JHS is caused by ... | Congenital malformation | ESCO2 [HSA:157570] [KO:K11268] | |
H02655 | Retinal dystrophy and microvillus inclusion disease | ... (STX3) cause this syndrome. Syntaxin genes code for N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins that catalyze the fusion between vesicles and their target membranes. | Congenital malformation | STX3 [HSA:6809] [KO:K08486] | |
H02704 | Mitochondrial myopathy and ataxia | ... myopathy and cerebellar ataxia. It has been reported that mutations in MSTO1 cause this disease. MSTO1 is a soluble cytoplasmic protein that regulates mitochondrial dynamics by promoting mitochondrial fusion. | Nervous system disease | MSTO1 [HSA:55154] [KO:K27320] | |
H02717 | Contractures, pterygia, and spondylocarpotarsal fusion syndrome | Contractures, pterygia, and spondylocarpotarsal fusion syndrome (CPSFS) is a myosinopathy characterized by contractures of proximal and distal joints, pterygia involving the neck, elbows, fingers, and/or ... | Congenital malformation | MYH3 [HSA:4621] [KO:K24220] | |
H02766 | Radiohumeral fusions with other skeletal and craniofacial anomalies | Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA) is a syndrome of fetal and infantile lethality with craniosynostosis and skeletal anomalies. It has been reported that mutations ... | Congenital malformation | CYP26B1 [HSA:56603] [KO:K12664] |
[ KEGG | DISEASE | DRUG | MEDICUS ] |